Inventor · disambiguated record
Jinyan Du
Also filed as: DU JINYAN
1 granted patent·10 pending applications·1 citations·filing 2015–2022
15Inventor score
Top patents by PatentIndex Score
11 records- 0174US12378318B2Proteins binding NKG2D, CD16 and a tumor-associated antigenDRAGONFLY THERAPEUTICS INC·Filed 2019·Granted Aug 5, 2025·1 cites·11 claims
- 0259US2021261668A1Proteins binding nkg2d, cd16, and egfr, ccr4, or pd-l1DRAGONFLY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0355US2023203202A1Proteins binding nkg2d, cd16 and 5t4DRAGONFLY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0452US2020216544A1Proteins binding nkg2d, cd16, and egfr, hla-e, ccr4, or pd-l1DRAGONFLY THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0551US2021206859A1Proteins binding nkg2d, cd16 and a tumor-associated antigenDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0650US2021363261A1Protein binding nkg2d, cd16 and a fibroblast activation proteinDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0746US2021214436A1Multi-specific binding proteins and improvements thereonDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0846US2021238290A1Proteins binding nkg2d, cd16 and p-cadherinDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0944US2021221894A1Proteins binding nkg2d, cd16 and an antigen associated with tumors, mdscs and/or tamsDRAGONFLY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1043US2020231679A1Proteins binding nkg2d, cd16 and a tumor-associated antigenDRAGONFLY THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1123US2015361503A1Methods for selecting therapeutics for treatment of her2+ cancersMERRIMACK PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jinyan Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →